{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:58:24Z","timestamp":1781344704738,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["POS-T3-AN-05"],"award-info":[{"award-number":["POS-T3-AN-05"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gilead Fellowship Program 2024","award":["25078"],"award-info":[{"award-number":["25078"]}]},{"name":"Unione Europea - Next Generation EU \u2018Piano Nazionale di Ripresa e Resilienza, Missione 4 - Com-ponente 2 \u2013 Investimento 1,1"},{"name":"Start up AIRC Grant","award":["20456"],"award-info":[{"award-number":["20456"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07073-2","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T02:21:54Z","timestamp":1779502914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia"],"prefix":"10.1007","volume":"105","author":[{"given":"Gaetano","family":"Cimino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sembenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zorutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Saldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cardinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Sciabolacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Matteucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"La Starza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pucciarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Zei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Iacucci Ostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Carotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mecucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-1729","authenticated-orcid":false,"given":"Maria Paola","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-7824","authenticated-orcid":false,"given":"Antonio","family":"Pierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"3","key":"7073_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/leu.2016.267","volume":"31","author":"S Struski","year":"2017","unstructured":"Struski S, Lagarde S, Bories P et al (2017) NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 31(3):565\u2013572","journal-title":"Leukemia"},{"issue":"9","key":"7073_CR2","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1002\/hem3.70013","volume":"8","author":"M Rasouli","year":"2024","unstructured":"Rasouli M, Troester S, Grebien F, Goemans BF, Zwaan CM, Heidenreich O (2024) NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunities. Hemasphere 8(9):e70013","journal-title":"Hemasphere"},{"issue":"2","key":"7073_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng0296-154","volume":"12","author":"T Nakamura","year":"1996","unstructured":"Nakamura T, Largaespada DA, Lee MP et al (1996) Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 12(2):154\u2013158","journal-title":"Nat Genet"},{"issue":"17","key":"7073_CR4","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood.2025028993","volume":"146","author":"M Umeda","year":"2025","unstructured":"Umeda M, Hiltenbrand R, Michmerhuizen NL et al (2025) Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia. Blood 146(17):2102\u20132118","journal-title":"Blood"},{"issue":"20","key":"7073_CR5","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1182\/blood.2020007093","volume":"136","author":"NL Michmerhuizen","year":"2020","unstructured":"Michmerhuizen NL, Klco JM, Mullighan CG (2020) Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies. Blood 136(20):2275\u20132289","journal-title":"Blood"},{"issue":"11","key":"7073_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228","journal-title":"Blood"},{"issue":"1","key":"7073_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41408-024-01066-y","volume":"14","author":"J Tian","year":"2024","unstructured":"Tian J, Zhu Y, Li J et al (2024) The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients. Blood Cancer J 14(1):81","journal-title":"Blood Cancer J"},{"issue":"1","key":"7073_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41408-025-01325-6","volume":"15","author":"W Huang","year":"2025","unstructured":"Huang W, Wang M, Xie J et al (2025) Adult AML with NUP98 rearrangements should be stratified into adverse-risk group. Blood Cancer J 15(1):113","journal-title":"Blood Cancer J"},{"issue":"9","key":"7073_CR9","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1182\/blood.V94.9.3258","volume":"94","author":"HG Ahuja","year":"1999","unstructured":"Ahuja HG, Felix CA, Aplan PD (1999) The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood 94(9):3258\u20133261","journal-title":"Blood"},{"issue":"3\u20134","key":"7073_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000458168","volume":"150","author":"K Yamamoto","year":"2016","unstructured":"Yamamoto K, Minami Y, Yakushijin K et al (2016) Coexpression of NUP98\/TOP1 and TOP1\/NUP98 in de novo Acute Myeloid Leukemia with t(11;20)(p15;q12) and t(2;5)(q33;q31). Cytogenet Genome Res 150(3\u20134):287\u2013292","journal-title":"Cytogenet Genome Res"},{"issue":"4","key":"7073_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1182\/blood-2003-10-3550","volume":"104","author":"RM Gurevich","year":"2004","unstructured":"Gurevich RM, Aplan PD, Humphries RK (2004) NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood 104(4):1127\u20131136","journal-title":"Blood"},{"issue":"8","key":"7073_CR12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3324\/haematol.2022.281653","volume":"108","author":"EJM Bertrums","year":"2023","unstructured":"Bertrums EJM, Smith JL, Harmon L et al (2023) Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica 108(8):2044\u20132058","journal-title":"Haematologica"},{"issue":"5","key":"7073_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","volume":"5","author":"A Pierini","year":"2021","unstructured":"Pierini A, Ruggeri L, Carotti A et al (2021) Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia. Blood Adv 5(5):1199\u20131208","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"7073_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood-2024-203492","volume":"144","author":"F Zorutti","year":"2024","unstructured":"Zorutti F, Saldi S, Ruggeri L et al (2024) Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy. Blood 144(Supplement 1):269\u2013269","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07073-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:48:19Z","timestamp":1781344099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["7073"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07073-2","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the local institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Written informed consent was obtained from all the subjects for participation in this study and publication of this article and any further research issues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Maria Paola Martelli declares honoraria\/consultancy at the scientific advisory board for Abbvie, Amgen, Be-One, BMS, Delbert, Janssen, Novartis, Pfizer, and Jazz Pharmaceuticals. MC and GC declare travel support from Jazz Pharmaceuticals. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}